Safety of biological therapies for psoriasis: Effects on reproductive potential and outcomes in male and female patients

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The effects of biological therapies for psoriasis on pregnancy outcomes and lactation, and male fertility and mutagenicity are common concerns in the clinical setting. There is relatively little evidence to guide the clinician and patient. Here, we review the safety profile of the commonly used biological therapies for psoriasis in individuals of reproductive potential. Safety data were derived from large-scale registries, adverse event reporting databases, clinical trials and case reports. We assessed the effect of each therapy on adverse pregnancy outcomes including congenital malformations, and lactation with maternal administration, and male fertility and potential mutagenicity with paternal administration. We provide applicable guidance to inform clinician and patient before and after conception. © 2014 British Association of Dermatologists.
    Original languageEnglish
    JournalBritish Journal of Dermatology
    Volume171
    Issue number3
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'Safety of biological therapies for psoriasis: Effects on reproductive potential and outcomes in male and female patients'. Together they form a unique fingerprint.

    Cite this